Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Ended earlyNCT03439085What this trial is testingDNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated CancersWho this might be right forHuman Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)UnknownNCT00905658What this trial is testingNutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+4 more Centre Oscar Lambret 120
Early research (Phase 1)Active Not RecruitingNCT03634267What this trial is testingMRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal CancerWho this might be right forHuman Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Cervical CarcinomaStage IB2 Cervical Cancer AJCC v8+14 more M.D. Anderson Cancer Center 26
Early research (Phase 1)Study completedNCT00002949What this trial is testingVinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the PelvisWho this might be right forBladder CancerCervical CancerEndometrial Cancer+1 more University of Chicago 33
Early research (Phase 1)Study completedNCT00287885What this trial is testingDocetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+5 more Masonic Cancer Center, University of Minnesota 18
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Not applicableUnknownNCT00601406What this trial is testingStudy of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerWho this might be right forBreast CancerCervical CancerEndometrial Cancer+7 more The Christie NHS Foundation Trust 2,200
Testing effectiveness (Phase 2)Study completedNCT01079832What this trial is testingStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological MalignanciesWho this might be right forFallopian Tube CancerOvarian SarcomaOvarian Stromal Cancer+23 more Case Comprehensive Cancer Center 50
Early research (Phase 1)Study completedNCT00082823What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Not applicableStudy completedNCT04269837What this trial is testingSexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic CancerWho this might be right forMalignant Female Reproductive System NeoplasmStage I Cervical Cancer AJCC v8Stage I Uterine Corpus Cancer AJCC v8+42 more Ohio State University Comprehensive Cancer Center 4
Early research (Phase 1)Study completedNCT00842452What this trial is testingTopotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by SurgeryWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+4 more Steven Waggoner, MD 26
Not applicableStudy completedNCT03339765What this trial is testingSelf-Advocacy Serious Game in Advanced CancerWho this might be right forOvarian Cancer Stage IIIOvarian Cancer Stage IVBreast Cancer Stage IV+10 more University of Pittsburgh 78
Large-scale testing (Phase 3)Active Not RecruitingNCT02466971What this trial is testingTesting the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal CancersWho this might be right forAdvanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell Carcinoma+18 more National Cancer Institute (NCI) 450
Early research (Phase 1)Study completedNCT00335998What this trial is testingPhase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic MalignanciesWho this might be right forRecurrent Cervical CancerRecurrent Ovarian Epithelial CancerRecurrent Vaginal Cancer+15 more National Cancer Institute (NCI) 24